Theralase Technologies, Inc. (TLT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Perimeter Medical Imaging AI, Inc.

Covalon Technologies Ltd.

Nanalysis Scientific Corp.

Profound Medical Corp.

Theralase Technologies, Inc.

Spectral Medical, Inc.

MedMira, Inc.

Ocumetics Technology Corp.

FuelPositive Corp.

VentriPoint Diagnostics Ltd.

Opsens, Inc.

Why is Theralase Technologies, Inc. ?

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 53.66%, its profits have fallen by -0.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Theralase Technologies, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Theralase Technologies, Inc.

53.66%

1.23

73.30%

S&P/TSX 60

23.72%

1.55

15.31%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.40%

EBIT Growth (5y)

7.52%

EBIT to Interest (avg)

-4.83

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.03

Sales to Capital Employed (avg)

0.59

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.05%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

70.57

EV to EBIT

-17.52

EV to EBITDA

-18.63

EV to Capital Employed

63.39

EV to Sales

77.16

PEG Ratio

Dividend Yield

ROCE (Latest)

-361.80%

ROE (Latest)

-398.39%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CAD -2.52 MM

NET PROFIT(HY)

Higher at CAD -1.96 MM

-4What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.39 times

RAW MATERIAL COST(Y)

Grown by 12.17% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 21.85 %

Here's what is working for Theralase Technologies, Inc.

Net Profit

Higher at CAD -1.96 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Operating Cash Flow

Highest at CAD -2.52 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Here's what is not working for Theralase Technologies, Inc.

Debtors Turnover Ratio

Lowest at 1.39 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Debt-Equity Ratio

Highest at 21.85 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 12.17% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales